Babassu mesocarp (Orbignya phalerata Mart) nanoparticle-based biosensors for indirect sulfite detection in industrial juices

Journal of Solid State Electrochemistry - The present work proposes a new electrochemical sulfite biosensor based on babassu mesocarp nanoparticles (BMNPs) immobilized on the surface of a pyrolytic...     

Optimization of the process variables in the microwave-induced synthesis of carbon xerogels

Carbon xerogels (CX) can be synthesized by microwave-assisted heating. The transfer of this technology to an industrial scale passes through the optimization of the variables that affect the process. The effect of the main operational variables, i.e., initial volume of the precursor, gelation and ageing time and temperature of the synthesis, on the final porous properties of CX has been evaluated. It was found that the development of porosity in the CX synthesised in the microwave oven is hardly influenced by the increase in the initial volume of the precursor solution. This suggests that it is feasible to scale up the production of these materials by means of microwave heating. Furthermore, the consumption of energy does not increase in proportion to the volume of xerogel synthesized. Thus, the process is energy efficient, saves a considerable amount of time and requires only a single device to carry it out. These advantages, along with the fact that a temperature variation of 10 °C is not determinative in the xerogels’ final properties, indicate that CX could be produced on a large scale in a cost effective way .     

Middle East respiratory syndrome coronavirus: transmission,virology and therapeutic targeting to aid in outbreak control

Middle East respiratory syndrome coronavirus (MERS-CoV) causes high fever, cough, acute respiratory tract infection and multiorgan dysfunction that may eventually lead to the death of the infected individuals. MERS-CoV is thought to be transmitted to humans through dromedary camels. The occurrence of the virus was first reported in the Middle East and it subsequently spread to several parts of the world. Since 2012, about 1368 infections, including ~487 deaths, have been reported worldwide. Notably, the recent human-to-human ‘superspreading'' of MERS-CoV in hospitals in South Korea has raised a major global health concern. The fatality rate in MERS-CoV infection is four times higher compared with that of the closely related severe acute respiratory syndrome coronavirus infection. Currently, no drug has been clinically approved to control MERS-CoV infection. In this study, we highlight the potential drug targets that can be used to develop anti-MERS-CoV therapeutics.